NDC 0019-1323
Optiray 320
Ioversol
Optiray 320 is a Intra-arterial; Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Liebel-flarsheim Company Llc. The primary component is Ioversol.
| Product ID | 0019-1323_0d687753-5c3f-47b3-921e-4c2f22ba6717 |
| NDC | 0019-1323 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Optiray 320 |
| Generic Name | Ioversol |
| Dosage Form | Injection |
| Route of Administration | INTRA-ARTERIAL; INTRAVENOUS |
| Marketing Start Date | 2012-03-04 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019710 |
| Labeler Name | Liebel-Flarsheim Company LLC |
| Substance Name | IOVERSOL |
| Active Ingredient Strength | 678 mg/mL |
| Pharm Classes | Radiographic Contrast Agent [EPC],X-Ray Contrast Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 0019-1323-00
20 SYRINGE, PLASTIC in 1 CARTON (0019-1323-00) > 100 mL in 1 SYRINGE, PLASTIC
| Marketing Start Date | 2012-03-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0019-1323-61 [00019132361]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA020923 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2011-10-17 |
NDC 0019-1323-83 [00019132383]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-02 [00019132302]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-16 [00019132316]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-85 [00019132385]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-81 [00019132381]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-77 [00019132377]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-78 [00019132378]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-90 [00019132390]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-75 [00019132375]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-11 [00019132311]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-91 [00019132391]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-27 [00019132327]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-52 [00019132352]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-00 [00019132300]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-95 [00019132395]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-70 [00019132370]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-41 [00019132341]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
| Marketing End Date | 2016-03-07 |
NDC 0019-1323-87 [00019132387]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-55 [00019132355]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-73 [00019132373]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-04 [00019132304]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-21 [00019132321]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
NDC 0019-1323-06 [00019132306]
Optiray 320 INJECTION
| Marketing Category | NDA |
| Application Number | NDA019710 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-03-04 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| IOVERSOL | 678 mg/mL |
OpenFDA Data
| SPL SET ID: | 6cb6ca5f-b249-49b0-a9eb-8aa583da7c74 |
| Manufacturer | |
| UNII | |
| UPC Code |
Pharmacological Class
- Radiographic Contrast Agent [EPC]
- X-Ray Contrast Activity [MoA]
NDC Crossover Matching brand name "Optiray 320" or generic name "Ioversol"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0019-1323 | Optiray | Ioversol |
| 0019-1324 | Optiray | Ioversol |
| 0019-1332 | Optiray | Ioversol |
| 0019-1333 | Optiray | Ioversol |
Trademark Results [Optiray]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OPTIRAY 73710159 1526467 Live/Registered |
MALLINCKRODT, INC. 1988-02-08 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.